Is checkpoint kinase 1 a suitable molecular target for combination with cancer chemotherapeutics?

Warning

This publication doesn't include Faculty of Arts. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	ZEMANOVÁ Jana ŠEBEJOVÁ Ludmila HYLSE Ondřej PARUCH Kamil POSPÍŠILOVÁ Šárka TRBUŠEK Martin
Year of publication	2014
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation
Related projects:	Časná identifikace CLL pacientů s dosud nevyselektovanými mutacemi v proteinu p53 Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit